- Details
-
Category: Bulk Drug Manufacturing
Apothecon Pharmaceuticals Ltd plans bulk drug unit at Dadhasa in Jambusar in Padra in Gujarat with an investment of Rs. 400 million. The unit will require hazardous raw materials like Toluene, Methanol, Acetone, Dichloromethane, Hexane, Ethyl acetate, Isopropyl alcohol, Ethanol, Butanol etc. The project involves setting up of manufacturing facilities to produce Colesevelam ( 20 mtpm), Aztreonam( 2mptm), Felbamate ( 6 mtpm), Fomepizole (1 mtpm), Iron sucrose complex ( 5 mtpm) and other chemicals. The unit will have a total production capacity of 79.75 mtpm. The plant will also produce by-products like sodium chloride and ammonium chloride.